iTr35细胞在系统性硬化症炎症反应与纤维化进展中的作用
本研究纳入68例系统性硬化症患者,检测iTr35与Tr1细胞亚群及IL-35、IL-10水平,并分析皮肤成纤维细胞纤维化相关基因与STAT3/6通路。结果显示iTr35细胞及IL-35升高而Tr1及IL-10降低,iTr35细胞可经STAT3/6通路影响α-SMA表达并抑制T细胞增殖分化,参与SSc炎症与纤维化。
要点
- SSc患者外周血iTr35细胞比例升高、Tr1细胞降低,IL-35升高而IL-10降低。
- SSc皮肤成纤维细胞EBI3、IL-12Ap35、Foxp3、IL-10降低,胶原I、TGF-β、α-SMA、纤连蛋白升高。
- rhIL-35与rhIL-10共孵育时iTr35与Tr1细胞数多于单用任一细胞因子。
核心结论
- iTr35和Tr1细胞均参与SSc相关炎症与纤维化,IL-35可诱导iTr35细胞并与IL-10产生协同效应。
- iTr35细胞可通过STAT3/6信号通路抑制T细胞增殖与分化,从而引起纤维化。
研究设计与样本
- 研究纳入68例系统性硬化症患者,采用流式细胞术检测iTr35与Tr1细胞亚群,ELISA检测IL-35与IL-10水平。
- 采用免疫荧光、蛋白质印迹和免疫组织化学法检测iTr35、Tr1及纤维化相关基因与信号通路蛋白表达。
主要发现
- 外周血iTr35细胞比例高于对照组,Tr1细胞低于对照组,IL-35表达升高而IL-10水平降低。
- 皮肤组织成纤维细胞中EBI3、IL-12Ap35、Foxp3和IL-10表达降低,胶原I、TGF-β、α-SMA和纤连蛋白水平升高。
- 磷酸化STAT3/6升高,而iTr35和Tr1细胞水平显著降低。
- CD4+细胞与rhIL-35及rhIL-10共孵育时,iTr35和Tr1细胞数多于单用rhIL-35或单用rhIL-10处理的同类细胞。
- 随iTr35细胞逐渐增加,常规CD4+ T细胞活力降低;iTr35细胞经STAT3/6信号通路影响α-SMA表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the role of induced immunosuppressive T regulatory (iTr) 35 cells in SSc-related inflammation and fibrosis. METHODS: Sixty-eight SSc patients were enrolled in this study. Subsets of iTr35 and Tr1 were measured by flow cytometry. IL-35 and IL-10 levels were measured using ELISA. Expressions of iTr35, Tr1, fibrosis-related genes and proteins associated with signalling pathways were determined using immunofluorescence, western blot and immunohistochemistry assays. RESULTS: In peripheral blood, the proportions of the iTr35 cells were higher and Tr1 cells were lower than the control group. Similarly, IL-35 expression was increased, while IL-10 levels were decreased. In fibroblasts from skin tissue, the expression levels of EBI3, IL-12Ap35, Foxp3 and IL-10 were decreased, but collagen I, TGF-β, alpha smooth muscle actin (α-SMA) and fibronectin levels were increased. Phosphorylated STAT3/6 were increased, but iTr35 and Tr1 cell levels were significantly decreased. When CD4+ cells were incubated with both recombinant human (rh)IL-35 and rhIL-10, the cell numbers of iTr35 and Tr1 were greater than the same type of cells treated with rhIL-35 or rhIL-10 alone. However, the viability of conventional CD4+ T cells was decreased by gradually increasing iTr35 cells. Moreover, iTr35 cells affected α-SMA expression through the STAT3/6 signalling pathway. CONCLUSION: Both iTr35 and Tr1 cells are involved in SSc-related inflammation and fibrosis. IL-35 can induce iTr35 cells, showing a synergistic effect with IL-10. We also found that iTr35 cells can inhibit T cell proliferation and differentiation via the STAT3/6 signalling pathway, thereby causing fibrosis.
引用
- Yang C, Lu C, Pan J, et al. The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis. Rheumatology (Oxford). 2023. PMID: 36734529. doi:10.1093/rheumatology/kead053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。